92: [177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): The NETTER-2 Study
Saved in:
Published in | Radiotherapy and oncology Vol. 174; pp. S40 - S41 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.09.2022
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0167-8140 |
---|---|
DOI: | 10.1016/S0167-8140(22)04371-7 |